Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

288 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized Trial of 2 Schedules of Meningococcal B Vaccine in Adolescents and Young Adults, Canada1.
Langley JM, Gantt S, Quach C, Bettinger JA, Halperin SA, Mutch J, McNeil SA, Ward BJ, MacKinnon-Cameron D, Ye L, Marty K, Scheifele D, Brown E, Alcantara J; Canadian Immunization Research Network. Langley JM, et al. Among authors: ward bj. Emerg Infect Dis. 2020 Mar;26(3):454-462. doi: 10.3201/eid2603.190160. Emerg Infect Dis. 2020. PMID: 32091358 Free PMC article. Clinical Trial.
Unusual patterns of IgG avidity in some young children following two doses of the adjuvanted pandemic H1N1 (2009) influenza virus vaccine.
Yam KK, Gupta J, Brewer A, Scheifele DW, Halperin S, Ward BJ; Public Health Agency of Canada/Canadian Institute of Health Research, Influenza Research Network (PCIRN) Rapid Trial Study 3 (RT-03) Investigators. Yam KK, et al. Among authors: ward bj. Clin Vaccine Immunol. 2013 Apr;20(4):459-67. doi: 10.1128/CVI.00619-12. Epub 2013 Jan 23. Clin Vaccine Immunol. 2013. PMID: 23345582 Free PMC article.
Safety and immunogenicity of 2010–2011 A/H1N1pdm09-containing trivalent inactivated influenza vaccine in adults previously given AS03-adjuvanted H1N1 2009 pandemic vaccine: results of a randomized trial.
Scheifele DW, Dionne M, Ward BJ, Cooper C, Vanderkooi OG, Li Y, Halperin SA; PHAC/CIHR Influenza Research Network. Scheifele DW, et al. Among authors: ward bj. Hum Vaccin Immunother. 2013 Jan;9(1):136-43. doi: 10.4161/hv.22619. Hum Vaccin Immunother. 2013. PMID: 23570051 Free PMC article. Clinical Trial.
Immunogenicity of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in nonresponders to licensed hepatitis B vaccine.
Halperin SA, Ward BJ, Dionne M, Langley JM, McNeil SA, Smith B, Mackinnon-Cameron D, Heyward WL, Martin JT. Halperin SA, et al. Among authors: ward bj. Hum Vaccin Immunother. 2013 Jul;9(7):1438-44. doi: 10.4161/hv.24256. Epub 2013 Apr 9. Hum Vaccin Immunother. 2013. PMID: 23571179 Free article.
Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparison.
Scheifele DW, McNeil SA, Ward BJ, Dionne M, Cooper C, Coleman B, Loeb M, Rubinstein E, McElhaney J, Hatchette T, Li Y, Montomoli E, Schneeberg A, Bettinger JA, Halperin SA; PHAC /CIHR Influenza Research Network. Scheifele DW, et al. Among authors: ward bj. Hum Vaccin Immunother. 2013 Nov;9(11):2460-73. doi: 10.4161/hv.25580. Epub 2013 Jul 9. Hum Vaccin Immunother. 2013. PMID: 23839537 Free PMC article. Clinical Trial.
Approved but non-funded vaccines: accessing individual protection.
Scheifele DW, Ward BJ, Halperin SA, McNeil SA, Crowcroft NS, Bjornson G. Scheifele DW, et al. Among authors: ward bj. Vaccine. 2014 Feb 7;32(7):766-70. doi: 10.1016/j.vaccine.2013.12.027. Epub 2013 Dec 25. Vaccine. 2014. PMID: 24374500 Free article. Review.
Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation.
Schneeberg A, Bettinger JA, McNeil S, Ward BJ, Dionne M, Cooper C, Coleman B, Loeb M, Rubinstein E, McElhaney J, Scheifele DW, Halperin SA. Schneeberg A, et al. Among authors: ward bj. BMC Public Health. 2014 May 12;14:442. doi: 10.1186/1471-2458-14-442. BMC Public Health. 2014. PMID: 24884433 Free PMC article.
Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial.
Vesikari T, Langley JM, Segall N, Ward BJ, Cooper C, Poliquin G, Smith B, Gantt S, McElhaney JE, Dionne M, van Damme P, Leroux-Roels I, Leroux-Roels G, Machluf N, Spaans JN, Yassin-Rajkumar B, Anderson DE, Popovic V, Diaz-Mitoma F; PROTECT Study Group. Vesikari T, et al. Among authors: ward bj. Lancet Infect Dis. 2021 Sep;21(9):1271-1281. doi: 10.1016/S1473-3099(20)30780-5. Epub 2021 May 11. Lancet Infect Dis. 2021. PMID: 33989539 Clinical Trial.
Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) study.
Bolotin S, Severini A, Hatchette T, McLachlan E, Savage R, Hughes SL, Wang J, Deeks SL, Wilson S, Brisson M, Halperin SA, Gubbay J, Mazzulli T, Serhir B, Ward BJ, Crowcroft N. Bolotin S, et al. Among authors: ward bj. Hum Vaccin Immunother. 2019;15(12):2856-2864. doi: 10.1080/21645515.2019.1619402. Epub 2019 Jul 16. Hum Vaccin Immunother. 2019. PMID: 31184979 Free PMC article.
288 results